119 related articles for article (PubMed ID: 20021298)
1. Filovirus vaccines: what challenges are left?
Bukreyev A; Collins PL
Expert Rev Vaccines; 2010 Jan; 9(1):5-8. PubMed ID: 20021298
[No Abstract] [Full Text] [Related]
2. Characterization of a putative filovirus vaccine: virus-like particles.
Martins KA; Warren TK; Bavari S
Virol Sin; 2013 Apr; 28(2):65-70. PubMed ID: 23385315
[TBL] [Abstract][Full Text] [Related]
3. Challenges, progress, and opportunities: proceedings of the filovirus medical countermeasures workshop.
Hirschberg R; Ward LA; Kilgore N; Kurnat R; Schiltz H; Albrecht MT; Christopher GW; Nuzum E
Viruses; 2014 Jul; 6(7):2673-97. PubMed ID: 25010768
[TBL] [Abstract][Full Text] [Related]
4. Filovirus infections.
Warfield KL; Deal EM; Bavari S
J Am Vet Med Assoc; 2009 May; 234(9):1130-9. PubMed ID: 19405883
[No Abstract] [Full Text] [Related]
5. Filovirus vaccines.
Bradfute SB; Dye JM; Bavari S
Hum Vaccin; 2011 Jun; 7(6):701-11. PubMed ID: 21519188
[TBL] [Abstract][Full Text] [Related]
6. Ebolavirus and Marburgvirus: insight the Filoviridae family.
Ascenzi P; Bocedi A; Heptonstall J; Capobianchi MR; Di Caro A; Mastrangelo E; Bolognesi M; Ippolito G
Mol Aspects Med; 2008 Jun; 29(3):151-85. PubMed ID: 18063023
[TBL] [Abstract][Full Text] [Related]
7. Outbreaks of filovirus hemorrhagic fever: time to refocus on the patient.
Bausch DG; Feldmann H; Geisbert TW; Bray M; Sprecher AG; Boumandouki P; Rollin PE; Roth C;
J Infect Dis; 2007 Nov; 196 Suppl 2():S136-41. PubMed ID: 17940941
[TBL] [Abstract][Full Text] [Related]
8. Advances in virus-like particle vaccines for filoviruses.
Warfield KL; Aman MJ
J Infect Dis; 2011 Nov; 204 Suppl 3(Suppl 3):S1053-9. PubMed ID: 21987741
[TBL] [Abstract][Full Text] [Related]
9. Protection against filovirus infection: virus-like particle vaccines.
Yang C; Ye L; Compans RW
Expert Rev Vaccines; 2008 Apr; 7(3):333-44. PubMed ID: 18393603
[TBL] [Abstract][Full Text] [Related]
10. Filovirus-like particles as vaccines and discovery tools.
Warfield KL; Swenson DL; Demmin G; Bavari S
Expert Rev Vaccines; 2005 Jun; 4(3):429-40. PubMed ID: 16026254
[TBL] [Abstract][Full Text] [Related]
11. The structural basis for filovirus neutralization by monoclonal antibodies.
King LB; West BR; Schendel SL; Saphire EO
Curr Opin Immunol; 2018 Aug; 53():196-202. PubMed ID: 29940415
[TBL] [Abstract][Full Text] [Related]
12. [Filovirus infection and host factors].
Takada A
Tanpakushitsu Kakusan Koso; 2009 Jun; 54(8 Suppl):913-9. PubMed ID: 21089517
[No Abstract] [Full Text] [Related]
13. Filovirus research: knowledge expands to meet a growing threat.
Bray M; Murphy FA
J Infect Dis; 2007 Nov; 196 Suppl 2():S438-43. PubMed ID: 17940981
[No Abstract] [Full Text] [Related]
14. Filovirus emergence and vaccine development: a perspective for health care practitioners in travel medicine.
Sarwar UN; Sitar S; Ledgerwood JE
Travel Med Infect Dis; 2011 May; 9(3):126-34. PubMed ID: 21208830
[TBL] [Abstract][Full Text] [Related]
15. Potential vaccines and post-exposure treatments for filovirus infections.
Friedrich BM; Trefry JC; Biggins JE; Hensley LE; Honko AN; Smith DR; Olinger GG
Viruses; 2012 Sep; 4(9):1619-50. PubMed ID: 23170176
[TBL] [Abstract][Full Text] [Related]
16. An interagency collaboration to facilitate development of filovirus medical countermeasures.
Kilgore N; Nuzum EO
Viruses; 2012 Oct; 4(10):2312-6. PubMed ID: 23202465
[TBL] [Abstract][Full Text] [Related]
17. Personal Protective Equipment for Filovirus Epidemics: A Call for Better Evidence.
Sprecher AG; Caluwaerts A; Draper M; Feldmann H; Frey CP; Funk RH; Kobinger G; Le Duc JW; Spiropoulou C; Williams WJ
J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S98-S100. PubMed ID: 25821225
[TBL] [Abstract][Full Text] [Related]
18. The Role of Cytokines and Chemokines in Filovirus Infection.
Bixler SL; Goff AJ
Viruses; 2015 Oct; 7(10):5489-507. PubMed ID: 26512687
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of perceived threat differences posed by filovirus variants.
Kuhn JH; Dodd LE; Wahl-Jensen V; Radoshitzky SR; Bavari S; Jahrling PB
Biosecur Bioterror; 2011 Dec; 9(4):361-71. PubMed ID: 22070137
[TBL] [Abstract][Full Text] [Related]
20. The role of reverse genetics systems in determining filovirus pathogenicity.
Theriault S; Groseth A; Artsob H; Feldmann H
Arch Virol Suppl; 2005; (19):157-77. PubMed ID: 16355872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
